Have a personal or library account? Click to login
Prediction of 2 years-survival in patients with stage I and II non-small cell lung cancer utilizing 18F-FDG PET/CT SUV quantifica Cover

Prediction of 2 years-survival in patients with stage I and II non-small cell lung cancer utilizing 18F-FDG PET/CT SUV quantifica

Radiology and Oncology
Volume 47 (2013): Issue 3 (September 2013)
By: Angelina Cistaro,  Natale Quartuccio,  Alireza Mojtahedi,  Piercarlo Fania,  Pier Luigi Filosso,  Alfredo Campenni,  Umberto Ficola and  Sergio Baldari  
Open Access
|Jul 2013

References

  1. 1. WHO Department of Gender, Women and Health. Gender in lung cancer andsmoking research. Geneva: World Health Organization; January 2004. p. 8.
    Search in Google Scholar
  2. 2. Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003; 348: 2500-7.10.1056/NEJMoa022136
    Search in Google Scholar
  3. 3. Baum RP, Hellwig D, Mezzetti M. Position of nuclear medicine modalities in the diagnostic workup of cancer patients: lung cancer. Q J Nucl Med MolImaging 2004; 48: 119-42.
    Search in Google Scholar
  4. 4. Hellwig D, Baum RP, Kirsch C. FDG PET, PET/CT and conventional nuclear medicine procedures in the evaluation of lung cancer: a systematic review. Nuklearmedizin 2009; 48: 59-69.10.3413/nukmed-0217
    Search in Google Scholar
  5. 5. Vansteenkiste J, Fisher BM, Dooms C, Mortensen J. Positron-emission tomography in prognostic and therapeutic assessment of lung cancer: systematic review. Lancet Oncol 2004; 5: 531-40.10.1016/S1470-2045(04)01564-5
    Search in Google Scholar
  6. 6. Chen HH, Chiu NT, Su WC, Guo HR, Lee BF. Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer. Radiology 2012; 264: 559-66.10.1148/radiol.12111148
    Search in Google Scholar
  7. 7. Goodgame B, Pillot GA, Yang Z, Shriki J, Meyers BF, Zoole J, et al. Prognostic value of preoperative positron emission tomography in resected stage I non-small cell lung cancer. J Thorac Oncol 2008; 3: 130-4.10.1097/JTO.0b013e318160c122
    Search in Google Scholar
  8. 8. Huang W, Zhou T, Ma L, Sun H, Gong H, Wang J, et al. Standard uptake value and metabolic tumour volume of ¹⁸F-FDG PET/CT predict short-term outcome early in the course of chemoradiotherapy in advanced non-small cell lung cancer. Eur J Nucl Med Mol Imaging 2011; 38: 1628-35.10.1007/s00259-011-1838-5
    Search in Google Scholar
  9. 9. Benz MR, Herrmann K, Walter F, Garon EB, Reckamp KL, Figlin R, et al. (18) F-FDG PET/CT for monitoring treatment responses to the epidermal growth factor receptor inhibitor erlotinib. J Nucl Med 2011; 52: 1684-9.10.2967/jnumed.111.095257
    Search in Google Scholar
  10. 10. Nesbitt JC, Putnam JB Jr, Walsh GL, Roth JA, Mountain CF. Survival in earlystage non-small cell lung cancer. Ann Thorac Surg 1995; 60: 466-72.10.1016/0003-4975(95)00169-L
    Search in Google Scholar
  11. 11. Gümüştaş S, Inan N, Akansel G, Ciftçi E, Demirci A, Ozkara SK. Differentiation of malignant and benign lung lesions with diffusion-weighted MR imaging. Radiol Oncol 2012; 46: 106-13.10.2478/v10019-012-0021-3347293223077446
    Search in Google Scholar
  12. 12. Collins LG, Haines C, Perkel R, Enck RE. Lung cancer: diagnosis and management. Am Fam Physician 2007; 75: 56-63.
    Search in Google Scholar
  13. 13. Andrade RS, Odell DD, D’Cunha J, Maddaus MA. Endobronchial ultrasonography (EBUS)-Its role in staging of non-small cell lung cancer and who should do it? J Thorac Cardiovasc Surg 2012; 144: S9-S13.10.1016/j.jtcvs.2012.03.06822898528
    Search in Google Scholar
  14. 14. American Joint Committee on Cancer. AJCC Cancer Staging Manual. 7th edition. New York: Springer; 2010. p. 299-324.
    Search in Google Scholar
  15. 15. Eisenhauera EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228-47.
    Search in Google Scholar
  16. 16. Beadsmoore CJ, Screton NJ. Classification, staging and prognosis of lung cancer. Eur J Radiol 2003; 45: 8-17.10.1016/S0720-048X(02)00287-5
    Search in Google Scholar
  17. 17. Weber WA, Ziegler SI, Thodtmann R, Hanauske AR, Schwaiger M. Reproducibility of metabolic measurements in malignant tumors using FDG PET. J Nucl Med 1999; 40: 1771-7.
    Search in Google Scholar
  18. 18. Huang SC. Anatomy of SUV. Standardized uptake value. Nucl Med Biol 2000; 27: 643-6.
    Search in Google Scholar
  19. 19. Adams MC, Turkington TG, Wilson JM, Wong TZ. A systematic review of the factors affecting accuracy of SUV Measurements. AJR Am J Roentgenol 2010; 195: 1043.10.2214/AJR.10.492320651185
    Search in Google Scholar
  20. 20. Boellaard R, O’Doherty MJ, Weber WA, Mottaghy FM, Lonsdale MN, Stroobants SG, et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging 2010; 37: 181-200.10.1007/s00259-009-1297-4279147519915839
    Search in Google Scholar
  21. 21. Cerfolio RJ, Bryant AS, Ohja B, Bartolucci AA. The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival. J Thorac Cardiovasc Surg 2005; 130: 151-9.10.1016/j.jtcvs.2004.11.00715999056
    Search in Google Scholar
  22. 22. Van Baardwijk A, Dooms C, Van Suylen RJ, Verbeken E, Hochstenbag M, Dehing-Oberije C, et al. The maximum uptake of (18)F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1alpha and GLUT-1 in non-small cell lung cancer. Eur J Cancer 2007; 43: 1392-8.10.1016/j.ejca.2007.03.02717512190
    Search in Google Scholar
  23. 23. Sasaki R, Komaki R, Macapinlac H. [18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer. JClin Oncol 2005; 23: 1136-43.10.1200/JCO.2005.06.12915718309
    Search in Google Scholar
  24. 24. Jeong HJ, Min JJ, Park JM, Kim BT, Jeong JM, Lee DS, et al. Determination of the prognostic value of [(18)F] fluorodeoxyglucose uptake by using positron emission tomography in patients with non-small cell lung cancer. Nucl MedCommun 2002; 23: 865-70.
    Search in Google Scholar
  25. 25. Downey RJ, Akhurst T, Gonen M, Vincent A, Bains MS, Larson S, et al. Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. J Clin Oncol 2004; 22: 3255-60.10.1200/JCO.2004.11.10915310769
    Search in Google Scholar
  26. 26. Vesselle H, Freeman JD, Wiens L, Stern J, Nguyen HQ, Hawes SE, et al. Fluorodeoxyglucose uptake of primary non-small cell lung cancer at positron emission tomography: New contrary data on prognostic role. ClinCancer Res 2007; 13: 3255-63.10.1158/1078-0432.CCR-06-112817545531
    Search in Google Scholar
  27. 27. Vansteenkiste JF, Stroobants SG, Dupont PJ, De Leyn PR, Verbeken EK, Deneffe GJ, et al. Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: an analysis of 125 cases. Leuven Lung Cancer Group. J Clin Oncol 1999; 17: 3201-6.10.1200/JCO.1999.17.10.320110506619
    Search in Google Scholar
  28. 28. Hanin FX, Lonneux M, Cornet J, Noirhomme P, Coulon C, Distexhe J, et al. Prognostic value of FDG uptake in early stage non-small cell lung cancer. EurJ Cardiothorac Surg 2008; 33: 819-23.10.1016/j.ejcts.2008.02.00518374589
    Search in Google Scholar
DOI: https://doi.org/10.2478/raon-2013-0023 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 219 - 223
Published on: Jul 30, 2013
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography,
non-small cell lung cancer,
maximum standardized uptake value,
disease-free survival,
overall survival
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2013 Angelina Cistaro, Natale Quartuccio, Alireza Mojtahedi, Piercarlo Fania, Pier Luigi Filosso, Alfredo Campenni, Umberto Ficola, Sergio Baldari, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Previous articleVolume 47 (2013): Issue 3 (September 2013)Next article